CLINICAL_TRIALS
trial_result
· 2019-10-31
Clinical Trial Update: The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study [Phase 1]
Summary
Phase 1 pharmacokinetic study of maraviroc with darunavir/ritonavir administered once daily in HIV patients has completed; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Imperial College London | Conditions: HIV | Phase 1 | Status: COMPLETED | Results posted: 2019-10-31